These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 123094)

  • 1. On the lysis of fibrin formed in the presence of dextran and other macromolecules.
    Wallenbeck IA; Tangen O
    Thromb Res; 1975 Jan; 6(1):75-86. PubMed ID: 123094
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of dextran 40 upon thrombin-induced fibrin deposition in rat lungs.
    Diffang C; Rammer L; Saldeen T
    Ups J Med Sci; 1976; 81(1):23-7. PubMed ID: 1273996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of histones and dextran on some properties of fibrin, particularly on its susceptibility to plasmin.
    Kppeć M; Wegrzynowicz Z; Zajdel M; Sawecka J; Szumiel I
    Thromb Res; 1974 Sep; 5(3):359-74. PubMed ID: 4280155
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of lytic effect on fibrin of immobilized heparin in complex with plasma proteins].
    Platé NA; Valuev LI; Gumirova FKh; Maklakova IA
    Vopr Med Khim; 1982; 28(5):19-23. PubMed ID: 6217639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of heparin, tranexamic acid, and low molecular weight dextran on pulmonary microvascular occlusions following aortic cross-clamping.
    Lim RC; Bergentz SE
    Bibl Anat; 1969; 10():480-8. PubMed ID: 5407404
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS; Rozenfeld MA; Leonova VB
    Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic activity in cantharide blisters of urticaria patients].
    Hadlich J
    Hautarzt; 1968 May; 19(5):203-6. PubMed ID: 4235008
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dextran on fibrinolysis inhibition activity in serum.
    Carlin G; Saldeen T
    Thromb Res; 1978 Jun; 12(6):1165-75. PubMed ID: 151346
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
    Teisseyre E; Latallo ZS; Kopeć M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):99-110. PubMed ID: 4134484
    [No Abstract]   [Full Text] [Related]  

  • 12. The antithrombotic effect of dextran-40 in man is due to enhanced fibrinolysis in vivo.
    Jones CI; Payne DA; Hayes PD; Naylor AR; Bell PR; Thompson MM; Goodall AH
    J Vasc Surg; 2008 Sep; 48(3):715-22. PubMed ID: 18572351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of heparin, plasmin, dextran and low-molecular-weight dextran on electrically induced thromboses.
    Flemma RJ; Acinapura AJ; Silver D; Anlyan WG
    Am Surg; 1966 Jan; 32(1):17-9. PubMed ID: 4221357
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen assay by means of the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-molecular heparin complex formation with the blood coagulation proteins--thrombin and fibrinogen].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1992; (5):802-6. PubMed ID: 1332992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of the antifibrinolytic activity in human plasma by means of the lysis time method.
    Ygge J; Berg W; Korsan-Bengtsen K
    Thromb Diath Haemorrh; 1968 Dec; 20(3):561-73. PubMed ID: 4237141
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural alterations in fibrin clots with dextran.
    Muzaffar TZ; Stalker AL; Bryce WA; Dhall DP
    Thromb Diath Haemorrh; 1972 Oct; 28(2):257-67. PubMed ID: 4639659
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.